Vutrisiran
- Generic Name
- Vutrisiran
- Brand Names
- Amvuttra
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1867157-35-4
- Unique Ingredient Identifier
- GB4I2JI8UI
- Background
Vutrisiran is a double-stranded small interfering ribonucleic acid (siRNA) that targets wild-type and mutant transthyretin (TTR) messenger RNA (mRNA). This siRNA therapeutic is indicated for the treatment of neuropathies associated with hereditary transthyretin-mediated amyloidosis (ATTR), a condition caused by mutations in the TTR gene. More than 130 TTR mu...
- Indication
Vutrisiran is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
- Associated Conditions
- Polyneuropathies
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath